Turner Pope Investments - Proposed Placing & Subscription to raise £1.05m
Research on TheraCryf PLC (TCF:LON) from Turner Pope Investments
TheraCryf plc announced a proposed capital raise of approximately £1.05 million through a placing and subscription of new ordinary shares at 0.18 pence each, alongside a share subdivision. The proceeds will fund the completion of the clinic-enabling program for its lead Orexin-1 antagonist addiction asset, aiming to secure a partnering deal. The company has also filed a process patent that could extend commercial protection until 2046 and identified an accelerated pathway for Phase 1 clinical trials in Australia, extending its cash runway to the end of Q1 2027.
View Full ResearchDisclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
